Cargando…

Research as an event: a novel approach to promote patient-focused drug development

Patient groups are increasingly engaging in research to understand patients’ preferences and incorporate their perspectives into drug development and regulation. Several models of patient engagement have emerged, but there is little guidance on how to partner with patient groups to engage the diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Jui-Hua, Janssen, Ellen, Bridges, John FP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939881/
https://www.ncbi.nlm.nih.gov/pubmed/29765204
http://dx.doi.org/10.2147/PPA.S153875
_version_ 1783321019127169024
author Tsai, Jui-Hua
Janssen, Ellen
Bridges, John FP
author_facet Tsai, Jui-Hua
Janssen, Ellen
Bridges, John FP
author_sort Tsai, Jui-Hua
collection PubMed
description Patient groups are increasingly engaging in research to understand patients’ preferences and incorporate their perspectives into drug development and regulation. Several models of patient engagement have emerged, but there is little guidance on how to partner with patient groups to engage the disease community. Our group has been using an approach to engage patient groups that we call research as an event. Research as an event is a method for researchers to use a community-centered event to engage patients in their own environment at modest incremental cost. It is a pragmatic solution to address the challenges of engaging patients in research to minimize patients’ frustration, decrease the time burden, and limit the overall cost. The community, the event, and the research are the three components that constitute the research as an event framework. The community represents a disease-specific community. The event is a meeting of common interest for patients and other stakeholders, such as a patient advocacy conference. The research describes activities in engaging the community for the purpose of research. Research as an event follows a six-step approach. A case study is used to demonstrate the six steps followed by recommendations for future implementation.
format Online
Article
Text
id pubmed-5939881
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59398812018-05-14 Research as an event: a novel approach to promote patient-focused drug development Tsai, Jui-Hua Janssen, Ellen Bridges, John FP Patient Prefer Adherence Perspectives Patient groups are increasingly engaging in research to understand patients’ preferences and incorporate their perspectives into drug development and regulation. Several models of patient engagement have emerged, but there is little guidance on how to partner with patient groups to engage the disease community. Our group has been using an approach to engage patient groups that we call research as an event. Research as an event is a method for researchers to use a community-centered event to engage patients in their own environment at modest incremental cost. It is a pragmatic solution to address the challenges of engaging patients in research to minimize patients’ frustration, decrease the time burden, and limit the overall cost. The community, the event, and the research are the three components that constitute the research as an event framework. The community represents a disease-specific community. The event is a meeting of common interest for patients and other stakeholders, such as a patient advocacy conference. The research describes activities in engaging the community for the purpose of research. Research as an event follows a six-step approach. A case study is used to demonstrate the six steps followed by recommendations for future implementation. Dove Medical Press 2018-05-03 /pmc/articles/PMC5939881/ /pubmed/29765204 http://dx.doi.org/10.2147/PPA.S153875 Text en © 2018 Tsai et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Perspectives
Tsai, Jui-Hua
Janssen, Ellen
Bridges, John FP
Research as an event: a novel approach to promote patient-focused drug development
title Research as an event: a novel approach to promote patient-focused drug development
title_full Research as an event: a novel approach to promote patient-focused drug development
title_fullStr Research as an event: a novel approach to promote patient-focused drug development
title_full_unstemmed Research as an event: a novel approach to promote patient-focused drug development
title_short Research as an event: a novel approach to promote patient-focused drug development
title_sort research as an event: a novel approach to promote patient-focused drug development
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939881/
https://www.ncbi.nlm.nih.gov/pubmed/29765204
http://dx.doi.org/10.2147/PPA.S153875
work_keys_str_mv AT tsaijuihua researchasaneventanovelapproachtopromotepatientfocuseddrugdevelopment
AT janssenellen researchasaneventanovelapproachtopromotepatientfocuseddrugdevelopment
AT bridgesjohnfp researchasaneventanovelapproachtopromotepatientfocuseddrugdevelopment